HELICOBACTER PYLORI INFECTION
Clinical trials for HELICOBACTER PYLORI INFECTION explained in plain language.
Never miss a new study
Get alerted when new HELICOBACTER PYLORI INFECTION trials appear
Sign up with your email to follow new studies for HELICOBACTER PYLORI INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Battle of the bacteria busters: triple vs quadruple therapy for stomach bug
Disease control ENROLLING_BY_INVITATIONThis study tests two different drug combinations to treat Helicobacter pylori, a stomach bacteria that can cause indigestion. About 66 adults with dyspepsia will receive either a triple therapy (amoxicillin, clarithromycin, esomeprazole) or a quadruple therapy (bismuth, metronida…
Matched conditions: HELICOBACTER PYLORI INFECTION
Phase: NA • Sponsor: Akil Al Islam • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Heart Patients' stomach ulcer prevention study pulled before starting
Prevention TerminatedThis study was designed to see if treating a common stomach bacteria (H. pylori) along with using a stomach acid drug could prevent ulcers caused by low-dose aspirin. It planned to enroll adults with heart or artery disease who needed long-term aspirin therapy. However, the study…
Matched conditions: HELICOBACTER PYLORI INFECTION
Phase: PHASE4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC